NOVADIOL
Novadiol is a Kansas-based biopharmaceutical company that develops innovative medicines for people with kidney diseases. The company's late-stage candidate, Dendocrin, is focused on chronic kidney disease (CKD) patients with secondary hyperparathyroidism (SHPT). Unlike new chemical entities (NCE’s), Dendocrin has relatively low development risk and low development costs. With a well-known safety and toxicity profile, Dendocrin is being re-positioned for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) stages 3 and 4 patients. Novadiol, Inc was founded in 2012 and Shawnee, KS, USA.
NOVADIOL
Industry:
Biotechnology Pharmaceutical
Founded:
2012-01-01
Address:
Shawnee, Kansas, United States
Country:
United States
Website Url:
http://www.novadiol.com
Total Employee:
1+
Status:
Active
Contact:
(913) 217-7168
Email Addresses:
[email protected]
Total Funding:
1.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Nginx Google Maps
Similar Organizations
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.novadiol.com Semrush global rank: 5.28 M Semrush visits lastest month: 1.56 K
- Host name: 100.164.174.34.bc.googleusercontent.com
- IP address: 34.174.164.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
